November’s roundup of articles features stories on the TPP trade deal, the AMA calling for a ban on drug advertising to consumers, gender inequality in science leadership, and even the science behind dragons.
Have a perspective on one of these stories? Submit your post to the AAPS Blog!
- “Pfizer and Allergan to Merge in $160 Billion Inversion,” by Carolyn Y. Johnson, The Washington Post, November 23, 2015
- “How to Hijack a Journal,” by John Bohannon, Science, November 20, 2015
- “FDA Moves Quickly to Approve Easy-to-use Nasal Spray to Treat Opioid Overdose,” FDA, November 18, 2015
- “AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices,” AMA, November 17, 2015
- “Birth Control Lawsuit Seeks Damages for Unplanned Pregnancies,” by Bill Chappell, The Two-Way, NPR, November 12, 2015
- “Gender Equality Still Major Problem in Science Leadership, Event Concludes,” by Julia Robinson, The Pharmaceutical Journal, November 12, 2015
- “Don’t Believe in Dragons? Just Check the Science behind Them,” by Dick Ahlstrom, The Irish Times, November 11, 2015
- “The TPP Trade Deal Cracks down on Big Tobacco—But Gives Drug Companies a Pass,” by Julia Belluz, Vox, November 6, 2015
- “New ORNL Device Combines Power of Mass Spectrometry, Microscopy,” DOE/Oak Ridge National Laboratory, EurkAlert!, November 6, 2015
- “The Life-saving Pill ‘Pharma Bro’ Increased to $750 Now Has a $1 Competitor,” by Elahe Izadi, The Washington Post, October 23, 2015
- “Many Antidepressant Studies Found Tainted by Pharma Company Influence,” by Roni Jacobson, Scientific American, October 21, 2015